BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19684903)

  • 21. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
    Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
    Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA aptamers binding to multiple prevalent M-types of Streptococcus pyogenes.
    Hamula CL; Le XC; Li XF
    Anal Chem; 2011 May; 83(10):3640-7. PubMed ID: 21504182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
    Watanabe S; Asamura H; Suzuki K; Tsuchiya R
    Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-SELEX selection of aptamers.
    Berezovski M; Musheev M; Drabovich A; Krylov SN
    J Am Chem Soc; 2006 Feb; 128(5):1410-1. PubMed ID: 16448086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Do pathologic-anatomic data influence the staging of non-small cell bronchial cancer?].
    Brambilla E
    Rev Mal Respir; 1992; 9 Suppl 4():R309-15. PubMed ID: 1336879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum tumor marker CYFRA 21-1 in the diagnostics of NSCLC lung cancer.
    Pavićević R; Milicić J; Bubanović G; Supe S
    Coll Antropol; 1998 Dec; 22(2):629-35. PubMed ID: 9887620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
    Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
    Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study.
    Tan D; Kirley S; Li Q; Ramnath N; Slocum HK; Brooks JS; Wu CL; Zukerberg LR
    Hum Pathol; 2003 Feb; 34(2):143-9. PubMed ID: 12612882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.
    Hasegawa H; Sode K; Ikebukuro K
    Biotechnol Lett; 2008 May; 30(5):829-34. PubMed ID: 18175068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple and rapid approach for measurement of dissociation constants of DNA aptamers against proteins and small molecules via automated microchip electrophoresis.
    Hu J; Easley CJ
    Analyst; 2011 Sep; 136(17):3461-8. PubMed ID: 21293790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selection of DNA aptamers, specifically interacting with fibrillar form of the yeast Sup35 protein].
    Surina ER; Morozkina EV; Marchenko EV; Ter-Avanesian MD; Benevolenskiĭ SV
    Mol Biol (Mosk); 2009; 43(4):682-8. PubMed ID: 19807032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid.
    Joeng CB; Niazi JH; Lee SJ; Gu MB
    Bioorg Med Chem; 2009 Aug; 17(15):5380-7. PubMed ID: 19604698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells.
    Smith JE; Medley CD; Tang Z; Shangguan D; Lofton C; Tan W
    Anal Chem; 2007 Apr; 79(8):3075-82. PubMed ID: 17348633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase.
    Mosing RK; Mendonsa SD; Bowser MT
    Anal Chem; 2005 Oct; 77(19):6107-12. PubMed ID: 16194066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
    Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
    Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.